Fetal Monitoring, Diagnostics and Predictive Tests

Apr 2023| HLC089C| BCC Publishing

Report Highlights

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Report Includes

  • 17 data tables and 54 additional tables
  • Detailed overview and an up-to-date analysis of the global market for fetal monitoring, prenatal diagnostics, and predictive tests
  • Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
  • Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
  • A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
  • Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
  • Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA

Report Scope

This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.

An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues. This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.

Frequently Asked Questions (FAQs)

The fetal monitoring, diagnostics and predictive tests market is projected to grow from $10.0 million in 2021 to $13.6 billion in 2027, at a compound annual growth rate (CAGR) of 5.6 % during the forecast period.
Key drivers of fetal monitoring, diagnostics and predictive tests market are expanding collaborations and strategic partnerships among academia and private players; continued investment by venture capitalists and pharma companies; and active support from the FDA.
The fetal monitoring, diagnostics and predictive tests market is segmented on the basis of applications,end user, and region.
Prenatal diagnostics segment will dominate the market by the end of 2027.
Key companies in the market includes
  • GE Healthcare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Beckman Coulter Inc.
  • Esaote SpA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $10.1 billion
Market size forecast $13.6 billion
Growth rate CAGR of 5.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered type and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered United States, Canada, France, Germany, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Australia, Singapore, Latin America, Middle East and Africa
Companies studied
  • ABBOTT
  • ABCAM PLC
  • AMBISEA TECHNOLOGY CORP. LTD.
  • ANSH LABS LLC.
  • ATOM MEDICAL CORP.
  • AVIVA SYSTEMS BIOLOGY LLC.
  • BECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)
  • BERRY GENOMICS
  • BIONET AMERICA INC.
  • BISTOS Co. LTD.
  • CONTEC MEDICAL SYSTEMS CO. LTD.
  • COOPERSURGICAL INC.
  • CREATIVE DIAGNOSTICS
  • DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
  • DEMEDITEC DIAGNOSTICS GMBH
  • DRAGERWERK AG & CO. KGAA
  • DRE INC.
  • DRG INTERNATIONAL INC.
  • EAGLE BIOSCIENCES INC.
  • EDAN INSTRUMENTS INC.
  • ESAOTE SPA
  • FUKUDA DENSHI CO. LTD.
  • GE HEALTHCARE
  • GENERAL MEDITECH INC.
  • HITACHI HEALTHCARE AMERICAS
  • HOLOGIC INC.
  • HUNTLEIGH HEALTHCARE LLC.
  • ILLUMINA INC.
  • INFINIUM MEDICAL
  • INSTITUTE OF ISOTOPES CO. LTD.
  • LEINCO TECHNOLOGIES INC.
  • LIFEWAVE BIOMEDICAL INC.
  • LUTECH INDUSTRIES INC.
  • M&B ELECTRONIC INSTRUMENTS CO. LTD.
  • MEDGYN PRODUCTS INC.
  • MEDIANA CO. LTD.
  • MEDICAL ECONET GMBH
  • MEDICHECKS LTD.
  • MINDCHILD MEDICAL INC.
  • MINDRAY MEDICAL INTERNATIONAL LTD.
  • MONOBIND INC.
  • MYRIAD GENETICS INC.
  • NATERA INC.
  • NATUS MEDICAL INC.
  • NEMO HEALTHCARE BV
  • NEOVENTA MEDICAL AB
  • NIHON KOHDEN CORP.
  • NONIN MEDICAL INC.
  • OB TOOLS LTD.
  • PENLON LTD.
  • PERKINELMER LIFE AND ANALYTICAL SCIENCES INC.
  • PHOENIX PHARMACEUTICALS INC.
  • RAVGEN
  • PREMAITHA HEALTH
  • QUEST DIAGNOSTICS INC.
  • RAYBIOTECH INC.
  • RESPIRONICS INC. (PHILIPS)
  • SEQUENOM INC.
  • SHENZHEN AEON TECHNOLOGY CO. LTD.
  • SHENZHEN COMEN MEDICAL INSTRUMENTS CO. LTD.
  • SHENZHEN JUMPER MEDICAL EQUIPMENT CO. LTD.
  • SIEMENS HEALTHINEERS AG
  • SINOHERO BIOMEDICAL ELECTRONICS CO. LTD.
  • SMITHS MEDICAL INC.
  • SPACELABS HEALTHCARE
  • CANON MEDICAL SYSTEMS CORP.
  • USCN LIFE SCIENCES INC.
  • ULTRASOUND TECHNOLOGIES LTD.
  • UNITED BIORESEARCH INC.
  • UTAH MEDICAL PRODUCTS INC.
  • VCOMIN TECHNOLOGY LTD.
  • WELCH ALLYN INC.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Fetal Monitoring, Diagnostics and Predictive Tests235Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights7Free
Chapter- 3: Market and Technology Background45Free
Chapter- 4: Emerging/Upcoming Technologies in the Market3Free
Chapter- 5: Regulatory Structure8Free
Chapter- 6: Market Breakdown by Application55Free
Chapter- 7: Impact of COVID-19 on the Market1Free
Chapter- 8: Competitive Landscape6Free
Chapter- 9: Company Profiles104Free
Published - Jan-2015| Analyst - Natana Raj| Code - HLC089B

Report Highlights

The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This market is expected to reach about $10.9 billion by 2019, with a compound annual growth rate (CAGR) of 4.0% from 2014 to 2019.

Report Includes

  • An overview of the global markets for fetal monitoring, diagnostics, and predictive tests.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
  • Discussion covering acquisitions, mergers, and alliances by companies and global organizations.
  • Comprehensive company profiles of major players in the industry.

Published - Apr-2011| Analyst - Shalini Shahani Dewan| Code - HLC089A

Report Highlights

The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010.  The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.

Fetal Monitoring, Diagnostics and Predictive Tests

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS